These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36078094)

  • 1. Potential Therapeutic Role of Mesenchymal-Derived Stem Cells as an Alternative Therapy to Combat COVID-19 through Cytokines Storm.
    Upadhyay TK; Trivedi R; Khan F; Pandey P; Sharangi AB; Goel H; Saeed M; Park MN; Kim B
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.
    Jeyaraman M; John A; Koshy S; Ranjan R; Anudeep TC; Jain R; Swati K; Jha NK; Sharma A; Kesari KK; Prakash A; Nand P; Jha SK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166014. PubMed ID: 33232817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
    Wang L; Li Y; Xu M; Deng Z; Zhao Y; Yang M; Liu Y; Yuan R; Sun Y; Zhang H; Wang H; Qian Z; Kang H
    Front Immunol; 2021; 12():726909. PubMed ID: 34394132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical role of mesenchymal stromal/stem cell therapy in COVID-19 patients: An updated review.
    Ebrahimi M; Rad MTS; Zebardast A; Ayyasi M; Goodarzi G; Tehrani SS
    Cell Biochem Funct; 2021 Dec; 39(8):945-954. PubMed ID: 34545605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
    Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Sadeghi S; Soudi S; Shafiee A; Hashemi SM
    Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.
    Khanh VC; Fukushige M; Chang YH; Hoang NN; Yamashita T; Obata-Yasuoka M; Hamada H; Osaka M; Hiramatsu Y; Ohneda O
    Stem Cells Dev; 2021 Aug; 30(15):758-772. PubMed ID: 34074129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapy for COVID-19 infection.
    Alavi-Dana SMM; Gholami Y; Meghdadi M; Fadaei MS; Askari VR
    Inflammopharmacology; 2024 Feb; 32(1):319-334. PubMed ID: 38117433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells.
    Generali M; Kehl D; Wanner D; Okoniewski MJ; Hoerstrup SP; Cinelli P
    J Cell Mol Med; 2022 Jan; 26(1):228-234. PubMed ID: 34821008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cytokine release syndrome-induced vascular endothelial injury using mesenchymal stem cells.
    Wang Y; Dong H; Dong T; Zhao L; Fan W; Zhang Y; Yao W
    Mol Cell Biochem; 2024 May; 479(5):1149-1164. PubMed ID: 37392343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study.
    Grumet M; Sherman J; Dorf BS
    Stem Cells Transl Med; 2022 Nov; 11(11):1103-1112. PubMed ID: 36181766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical progress in MSC-based therapies for the management of severe COVID-19.
    Rossello-Gelabert M; Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM
    Cytokine Growth Factor Rev; 2022 Dec; 68():25-36. PubMed ID: 35843774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
    Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
    Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
    Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
    Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19.
    Li X; Yan M; Chen J; Luo Y
    Biomed Res Int; 2021; 2021():3178796. PubMed ID: 34840969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.